Health Oversight Letters

06.02.25	acrobatScott, DeSaulnier Letter to DOL re ERISA Advisory Council
04.15.25	acrobatScott Letter to HHS re: Trump Administration Gutting Poverty Guideline Office
04.11.25	acrobatLetter to HHS Secretary Kennedy re: Marketplace Integrity and Affordability Proposed Rule
04.08.25	acrobatScott Letter to HHS re: Restructuring & Reduction in Force
04.08.25	acrobatLetter to Chair Walberg re: HHS Hearing
02.25.25	acrobatScott Letter to HHS CIO re: DOGE Access to Sensitive Data
02.05.25	acrobatLetter to Comptroller General re: Medicare Drug Price Negotiation
04.15.24	acrobatLetter to DOL re: Disability and Mental Health Parity Enforcement
06.28.22	acrobatChairman Scott Oversight Letter to HHS re: Medical Equipment Accessibility
06.13.22	acrobatScott, Pallone Letter to FTC re Online Infant Formula Price Gouging
06.02.22	acrobatChairman Scott Letter to Secretaries Vilsak and Becerra re: Infant Formula Stockpile
01.27.22	acrobatBicameral Health Leaders Applaud Biden Administration’s Proposed ACA Marketplace Rule
01.26.22	acrobatChairman Scott joint letter to Secretary Becerra and Administrator Brooks-LaSure re: Expressing strong support for the policies included in the proposed Notice of Benefit and Payment Parameters for 2023.
10.06.21	acrobatChairman Scott letter to Secretary Becerra, Secretary Walsh and Secretary Yellen re: Urging strong enforcement of the Affordable Care Act’s requirements that ensure consumers have access to the full range of U.S. Food and Drug Administration approved contraceptives without any cost-sharing
04.06.21	acrobatBicameral Letter to HHS Regarding Special Enrollment Period